our medium-term business plan
[Wastewater-based Epidemiology Surveillance Service]

[Wastewater-based Epidemiology Surveillance Service]

By measuring the traces of the virus in wastewater, it is possible to assess, in an unbiased manner, the prevalence of SARS-CoV-2 infections in a community, including asymptomatic individuals who are not tested.

Drive Innovation

［Innovation］

Drive Innovation

Create innovations beyond the borders of medical / Pharmaceutical fields, unbound from existing concepts, showing every consideration for social issues

Sustainability

［Sustainability］

Grow sustainably as a drug discovery based pharmaceutical company contributing to a more vigorous society through improved healthcare

News

Nov.30, 2023 Release
Regarding the Acquisition of Manufacturing and Marketing Approval for the New Siderophore Cephalosporin Antibiotic FetrojaⓇ(cefiderocol) Intravenous Infusion 1g vial in Japan
Nov.16, 2023 Release
Stream-I, Inc. Launches New Home Palliative Care Support Service 'Home Care Base'
Nov.08, 2023 Release
Notice Regarding the Status (Progress Report) of Acquisition of Own Shares (Acquisition of own shares pursuant to the provision of Article 165, Paragraph 2 of the Companies Act)
Nov.06, 2023 Notice
Transcript of the FY2023 2Q Financial Results Conference
Nov.06, 2023 Release
Notice of Investment with J.P. Morgan Asset Management’s Life Sciences Private Capital
News

Commitment to Fight COVID-19

Shionogi's effort to fight with COVID-19

Beware of Solicitations, “Phishing” e-mails, and SNS that Fraudulently Use the Name of SHIONOGI

Site Search

Brand Statement

Building innovation platforms to shape the future of healthcare.

SHIONOGI is transforming our business model from a "drug-discovery-oriented pharmaceutical company" to a "healthcare provider" to pursue the health that people truly wish for and deliver new value to society.

more

About Shionogi

We are fully committed to achieving the goals of STS2030 and strive to realizing "SHIONOGI Group heritage" globally.

Sustainability

Shionogi's susutainability programs which toward to become a company that will be needed by stakeholders now and in the future.

Innovation

Shionogi's Innovation always comes from the passion to provide new value which meet the needs of society and customers, in the healthcare field.

Investors

Based on disclosure policy, Shionogi disclose information fairly, timely, appropriately and continuously to all stakeholders.